D
Derek P. Chew
Researcher at Flinders University
Publications - 393
Citations - 21169
Derek P. Chew is an academic researcher from Flinders University. The author has contributed to research in topics: Myocardial infarction & Acute coronary syndrome. The author has an hindex of 60, co-authored 342 publications receiving 18879 citations. Previous affiliations of Derek P. Chew include Flinders Medical Centre & Auckland City Hospital.
Papers
More filters
Journal ArticleDOI
Evidence-based care in a population with chronic kidney disease and acute coronary syndrome. Findings from the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events (CONCORDANCE).
Jerrett K. Lau,Malcolm Anastasius,Karice Hyun,Bilyana Dabin,S. Coverdale,C. Ferry,Joseph Hung,Paul Antonis,Derek P. Chew,B. Aliprandi-Costa,Alan Cass,David Brieger +11 more
TL;DR: In this article, the authors describe the gaps in evidence-based care offered to patients with acute coronary syndrome and concomitant chronic kidney disease (CKD) and show that CKD independently predicts failure to undergo CA but not failure to receive EBM or CR.
Journal ArticleDOI
Bivalirudin in percutaneous coronary intervention.
Sam J. Lehman,Derek P. Chew +1 more
TL;DR: The pharmacology of bivalirudin and clinical trial evidence to date are reviewed, showing a reduction in rates of bleeding without loss of anti-thrombotic efficacy has been a consistent finding across multiple clinical trials.
Journal ArticleDOI
GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome
Inna Y. Gong,Shaun G. Goodman,Shaun G. Goodman,David Brieger,Chris P Gale,Derek P. Chew,Robert C. Welsh,Thao Huynh,J. Paul DeYoung,Carolyn Baer,Gabor Gyenes,Jacob A. Udell,Keith A.A. Fox,Andrew T. Yan,Andrew T. Yan +14 more
TL;DR: The GRACE RS is a valid predictor of in-hospital mortality for both men and women with ACS and the lack of interaction between sex and RS components suggests that sex-based modification is not required.
Journal ArticleDOI
Treatment disparities and effect on late mortality in patients with diabetes presenting with acute myocardial infarction: observations from the ACACIA registry
Joseph Hung,David Brieger,John Amerena,S. Coverdale,James M. Rankin,Carolyn Astley,Ashish Soman,Derek P. Chew +7 more
TL;DR: To compare the use of evidence‐based pharmacological and invasive treatments and 12‐month mortality rates between patients with and without diabetes who present with acute myocardial infarction, and to explore the relationship between these treatments and late clinical outcomes.
Journal ArticleDOI
Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
Gerald Yong,Jamie Rankin,Louise Ferguson,J. Thom,John K. French,David Brieger,Derek P. Chew,Ronald Dick,David Eccleston,Bernard E.F. Hockings,Darren L. Walters,Alan Whelan,John W. Eikelboom +12 more
TL;DR: These data confirm a modest incremental antiplatelet effect of a 600-mg clopidogrel LD compared with 300-mg LD but provide no support for a clinical benefit in patients with NSTEACS managed with an early invasive strategy.